Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2021
Date Filed: February 11, 2021
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing serves as a cleansing notice under Appendix 2A and Section 708A(5) and is incorporated by reference into the company's Registration Statements on Form S-8 and Form F-3.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing focuses on regulatory compliance and the incorporation of previous registration statements.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, specific risks, contingencies, or unusual items. The document is limited to the formal submission of a cleansing notice.
Investor Verification Checklist
- Verify the status of the Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, 333-228671) and Form F-3 (Files No. 333-249311, 333-231417, 333-250076) referenced in this filing.
- Confirm the specific details of the "Appendix 2A and Section 708A(5) Cleansing Notice" by reviewing the full text of the referenced documents, as this filing only cites them.
- Check for separate filings (e.g., Form 20-F or quarterly reports) to obtain actual financial performance data for the period.